Latest market price
2.35
-0.03-1.26%
OverviewShort InterestFilings
SSIIQT15SS Innovations International, Inc.·NASDAQ
2.35-1.26%
TA
Loading chart...
Signal & projected range
Gap down — mean-reversionHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
CERS-6.56%$2.28DCTH-4.10%$14.04TCMD-5.22%$23.04NPCE-5.46%$12.30OFIX-11.43%$9.07AVR-1.71%$6.31CLPT-0.19%$10.67BBNX-4.72%$16.75
Snapshot
Index—P/E—EPS (ttm)-0.07Insider Own—Shs Outstand200.48MPerf Week4.44%
Market Cap471.12MForward P/E—EPS next Y-0.06Insider Trans-0.01%Shs Float7.74MPerf Month-14.55%
Enterprise Value460.12MPEG—EPS next Q-0.01Short Float0.90%Perf Quarter-40.51%
Income-13.00MP/S8.89EPS this Y—Short Ratio1.09Perf Half Y-41.10%
Sales53.00MP/B8.89EPS next Y—ROA-12.82%Short Interest69.59KPerf YTD-58.63%
Book/sh0.26P/C33.67EPS next 5Y—ROE-26.77%52W High8.83 -73.39%Perf Year-72.83%
Cash/sh0.07P/FCF—EPS past 3/5Y—ROIC-12.92%52W Low2.20 6.82%Perf 3Y83.59%
Dividend Est.—EV/EBITDA—Sales past 3/5Y247.60% —Gross Margin47.01%Volatility11.86% 8.84%Perf 5Y1707.69%
Dividend TTM—EV/Sales8.68EPS Y/Y TTM—Oper. Margin-16.22%ATR (14)0.22Perf 10Y—
Dividend Ex-Date—Quick Ratio1.66Sales Y/Y TTM112.00%Profit Margin-23.73%RSI (14)35.98Recom—
Dividend Gr. 3/5Y—Current Ratio2.24EPS Q/Q—SMA20-6.97%Beta—Target Price7.00
Payout0.00%Debt/Eq0.06Sales Q/Q40.00%SMA50-20.58%Rel Volume0.87Prev Close2.38
Employees483LT Debt/Eq0.06EarningsNov 02SMA200-39.43%Avg Volume57.26KPrice2.35
IPO DateOct 17, 2018Option/ShortNo / YesEPS/Sales Surpr.0.00% 16.16%Net Debt/EBITDA—Volume49,668Change-1.26%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-03-26ReiteratedLoop Capital Markets$7.00
Latest News· Times ET
Oct-26-26
Oct-26-2603:30PM
SS Innovations International (SSII) Showcases Robotic Telesurgery Capabilities at International Medical ConferencesYahoo
08:30AM
SS Innovations Showcases SSi Mantra Telesurgery Capabilities at October 2026 Conferencesglobenewswire.com
Oct-23-26
Oct-23-2602:45PM
SSi Falls 32% in Three Months: Should You Buy the Dip or Wait?zacks.com
Oct-18-26
Oct-18-2602:01AM
SS Innovations International (NASDAQ:SSII) Shares Gap Down – Here’s What Happeneddefenseworld.net
Oct-14-26
Oct-14-2602:30PM
SS Innovations International (SSII) Submits FDA Response for SSi Mantra Surgical Robotic SystemYahoo
Oct-13-26
Oct-13-2608:30AM
SS Innovations Submits Response to FDA Request for Additional Information Regarding the Company's 510(k) Submission for the SSi Mantraglobenewswire.com
03:15AM
Comparing SS Innovations International (NASDAQ:SSII) and Terumo (OTCMKTS:TRUMY)defenseworld.net
Oct-12-26
Oct-12-2606:40AM
2 International Microcaps for Your Watchlistzacks.com
01:45AM
Critical Survey: OrthoPediatrics (NASDAQ:KIDS) vs. SS Innovations International (NASDAQ:SSII)defenseworld.net
Oct-09-26
Oct-09-2603:06PM
Zacks Initiates Coverage of SSi With Neutral Recommendationzacks.com
Oct-08-26
Oct-08-2603:30PM
SS Innovations International(SSII) Builds Telerobotic Surgery Position as Remote Procedures Gain GroundYahoo
Sep-25-26
Sep-25-2603:30PM
SS Innovations International (SSII) Expands Robotic Cardiac Surgery Footprint With New Program at HCG Hospital in AhmedabadYahoo
Sep-17-26
Sep-17-2603:00PM
SS Innovations International (SSII) Expands Global Footprint as SSi Mantra Procedures Reach 14,103Yahoo
Sep-11-26
Sep-11-2602:31PM
SS Innovations International (SSII) Brings Robotic Cardiac Surgery to Sri LankaYahoo
Sep-10-26
Sep-10-2608:30AM
SS Innovations Provides Update on Continuing Progress and Milestonesglobenewswire.com
Company

SS Innovations International, Inc., situated in Fort Lauderdale, Florida, focuses on the development of sophisticated robotic systems for surgical use. Their offerings encompass the SSI Mantra, a specialized surgical robot, and SSI Mudra, a suite of surgical instruments designed to facilitate various operations, including robotic cardiac surgery. The company also provides SSI Maya, a dedicated platform for robotic surgical interventions, along with OMNI 3D HD, which delivers a real-time, high-definition 3D perspective of the surgical field within the operating room.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue5342216—————
Cost of Goods Sold Incl. D&A2823125—————
Gross Profit242081—————
Selling, General and Administrative Excl. Other24232521—————
Research and Development5421—————
Other Operating Expense410-1—————
Operating Income-9-8-19-21—————
Interest Expense0111—————
Unusual Expense
—————————
Non-Operating Income (Expense)1110—————
Net Income Before Taxes-8-8-19-21—————
Income Taxes5400—————
Consolidated Net Income-13-12-19-21—————
Net Income From Continuing Operations-13-12-19-21—————
Net Income-13-12-19-21—————
EPS (Recurring)-0.07-0.06-0.11-0.16—————
EPS (Basic, Before Extraordinaries)-0.07-0.06-0.11-0.16—————
EPS (Diluted)-0.07-0.06-0.10-0.16—————
EBITDA-6-6-18-20—————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio
—————————
Price To Sales Ratio8.8725.7064.2515.47—————
Gross Margin45.2847.6238.1016.67—————
Operating Margin-16.98-19.05-90.48-350.00—————
Net Margin-24.53-28.57-90.48-350.00—————
Shares Outstanding200190171128—————
Market Capitalization4701,0791,34993—————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$11.14$8.63$6.12$3.60$1.09● Close Price0.00M1.30M2.60M3.90M5.20MUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Sudhir SrivastavaChairman and CEOSep 04 '26Sale3.0033,33399,999108,520,928Sep 09
MOLL FREDERIC HDirector, 10% OwnerMar 06 '26Buy3.99501,2531,999,99910,775,485Mar 10
Adams Timothy P.DirectorMar 06 '26Buy3.99300,0001,197,0005,331,902Mar 10
Sudhir SrivastavaChairman and CEOMar 06 '26Buy4.01498,7532,000,000109,851,767Mar 10
Cohen Barry FCOO - AmericasApr 22 '25Buy8.976525,8488,866,888Jun 30
Cohen Barry FCOO - AmericasApr 17 '25Buy8.752001,7508,866,562Jun 30
Cohen Barry FCOO - AmericasApr 16 '25Buy9.501071,0178,843,780Apr 16
Cohen Barry FCOO - AmericasApr 14 '25Buy8.931039208,843,673Apr 16
Cohen Barry FCOO - AmericasApr 10 '25Buy8.932001,7868,843,570Apr 10
Cohen Barry FCOO - AmericasApr 09 '25Buy8.473002,5408,843,370Apr 10
Cohen Barry FCOO - AmericasApr 08 '25Buy9.165004,5808,843,070Apr 10
Cohen Barry FCOO - AmericasApr 02 '25Buy9.204203,8648,842,570Apr 02
Cohen Barry FCOO - AmericasApr 01 '25Buy9.722,57024,9838,842,150Apr 02
Cohen Barry FCOO - AmericasMar 31 '25Buy10.001001,0008,839,580Apr 02
MOLL FREDERIC HDirector, 10% OwnerFeb 20 '25Buy1.373,645,2245,001,24710,060,813Feb 24
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.